DAWN — Day One Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Day One Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	284	342	366	532	441
Net Total Accounts Receivable
Net Total Receivables	—	—	—	13.9	26.7
Total Inventory
Prepaid Expenses
Total Current Assets	289	348	375	562	485
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.284	0.719	0.56	4.71	4.48
Net Intangible Assets
Long Term Investments
Total Assets	290	349	376	583	508
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	8.66	16.6	29.5	73.5	60.5
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	8.67	17	29.5	80	66.7
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	281	332	347	503	441
Total Liabilities & Shareholders' Equity	290	349	376	583	508
Total Common Shares Outstanding